Study of KAI-4169 to Treat Secondary Hyperparathyroidism in Hemodialysis Subjects

Written by ClinicalTrials.gov

Category: Bone diseases

Published: 09 August 2011

Condition: Secondary Hyperparathyroidism
Intervention: Drug: KAI-4169
Sponsor: KAI Pharmaceuticals
Not yet recruiting - verified August 2011

Details: Last Updated: 09 August 2011

Find, Use, Share, Expand Orthopaedic Information

Improving orthopaedic care, education and research using Internet technologies